Brief introduction of 1603-79-8

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 1603-79-8, Computed Properties of https://www.ambeed.com/products/1603-79-8.html.

Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In an article, author is Takaoka, Naoki, once mentioned the application of 1603-79-8, Name is Ethyl benzoylformate, molecular formula is C10H10O3, molecular weight is 178.1846, MDL number is MFCD00009120, category is phthalazine. Now introduce a scientific discovery about this category, Computed Properties of https://www.ambeed.com/products/1603-79-8.html.

As aldehyde oxidase (AOX) plays an emerging role in drug metabolism, understanding its significance for drug-drug interactions (DDI) is important. Therefore, we tested 10 compounds for species-specific and substrate-dependent differences in the inhibitory effect of AOX activity using genetically engineered HEK293 cells over- expressing human AOX1, mouse AOX1 or mouse AOX3 The IC50 values of 10 potential inhibitors of the three AOX enzymes were determined using phthalazine and O-6-benzylguanine as substrates 17 beta-Estradiol, mena dione, norharmane and raloxifene exhibited marked differences in inhibitory effects between the human and mouse AOX isoforms when the phthalazine substrate was used. Some of the compounds tested exhibited substrate dependent differences m their inhibitory effects. Docking simulations with human AOX1 and mouse AOX3 were conducted for six representative inhibitors. The rank order of the minimum binding energy reflected the order of the corresponding IC50 values. We also evaluated the potential DDI between an AOX substrate (O-6-benzylguanine) and an inhibitor (hydralazine) using chimeric mice with humanized livers. Pretreatment of hydralazine increased the maximum plasma concentration (C-max) and the area under the plasma concentration- time curve (AUC(0-24)) of O-6-benzylguanine compared to single administration. Our in vitro data indicate species-specific and substrate-dependent differences in the inhibitory effects on AOX activity. Our in vivo data demon strate the existence of a DDI which may be of relevance in the clinical context.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 1603-79-8, Computed Properties of https://www.ambeed.com/products/1603-79-8.html.

Reference:
Phthalazine – Wikipedia,
,Phthalazine | C8H6N2 – PubChem